September 01, 2016
A Texas federal judge on Thursday gave preliminary approval of a settlement that would pay shareholders of Pain Therapeutics Inc. up to $8.5 million and release claims the company hid from the market manufacturing issues with its pain treatment Remoxy.
July 08, 2015
A federal Texas judge on Tuesday ordered attorneys for a putative class accusing Pain Therapeutics Inc. of misleading investors about the prospects for painkiller Remoxy to refile their complaint and restart the class from the beginning in order to proceed, pushing the trial date back to March 2017.
November 05, 2014
Plaintiffs in a putative class action accusing Pain Therapeutics Inc. of misleading investors about the prospects for painkiller Remoxy attributed to a confidential witness statements that the man now claims he never made, the pharmaceutical company told a Texas federal court Tuesday.
November 20, 2012
A Texas federal judge refused Tuesday to derail a putative class action accusing Pain Therapeutics Inc. of misleading investors about the prospects for painkiller Remoxy, saying there was plausible evidence executives might have concealed damaging information about the drug.
September 26, 2012
A Texas federal judge on Wednesday dismissed a class action alleging Pain Therapeutics Inc.'s brass misled investors into thinking the biopharmaceutical company's newly developed painkiller would receive U.S. Food and Drug Administration approval, when it ultimately did not.